Effect of Cloves and Turmeric on Hyperlipidemic Diabetics

Effect of Cloves and Turmeric on Hyperlipidemic Diabetics


Tripathi MA, Tripathi A, Sharma V


Abstract

Cloves essential oil is used as an anodyne (pain killer) for dental emergencies as carminative and to increase the hydrochloric acid in the stomach and to improve peristalsis. Recent research has revealed that turmeric is a natural wonder, proving beneficial in the treatment of many different health conditions from cancer to Alzheimer’s disease. There are also evidences that spices can boost insulin function and lower cholesterol. Diabetes mellitus is potent, independent risk factors for cardiovascular disease. It has been projected that by 2020, chronic diseases will account for almost three quarters of all deaths worldwide and 71% of deaths due to ischemic heart disease,75% of death due to stroke and 70% of death due to diabetes will occur in developing countries. With this back ground, study was undertaken with the following objectives: (1) Prepared the spice capsules and supplement the diets of selected hyperlipidemic, diabetic adults for a period of three months and (2) Evaluated the effect using various parameters. The survey revealed that among the 45 adults with hyperlipidemic and diabetes mellitus a majority of 30.4% were in the age of 40-45 years, all the adults were literate. About 70% of the adults were either employed in private or government sector or engaged in business. 47% of the families were of joint type and 53% of them were nuclear type 45%.The positive impact of spices on hyperlipidemic diabetic adults is encouraging and being a dietary intervention it is devoid of other possible side effects, proving that spices supplementation is a cost effective and sustainable strategy in the management of hyperlipidemia and diabetes mellitus.


Keywords

Diabetes mellitus, Cardiovascular Disease, Alzheimer’s Disease, Cholesterol


Cite This Article

Tripathi, M. A., Tripathi, A., & Sharma, V. (2014). Effect of Cloves and Turmeric on Hyperlipidemic Diabetics. International Journal for Pharmaceutical Research Scholars, 3(1), 599-606.

Download Google Citation Back